First experiences with 177Lu-PSMA-617 therapy for recurrent or metastatic salivary gland cancer

被引：0
|
作者：
Thomas J. W. Klein Nulent
Robert J. J. van Es
Stefan M. Willems
Arthur. J. A. T. Braat
Lot A. Devriese
Remco de Bree
Bart de Keizer
机构：
[1] University Medical Center Utrecht,Department of Head and Neck Surgical Oncology
[2] University Medical Center Utrecht,Department of Oral and Maxillofacial Surgery
[3] University Medical Center Utrecht,Department of Pathology
[4] University Medical Center Groningen,Department of Pathology and Medical Biology
[5] University Medical Center Utrecht,Department of Radiology and Nuclear Medicine
[6] University Medical Center Utrecht,Department of Medical Oncology
来源：
EJNMMI Research | / 11卷
关键词：
Lutetium; Positron-emission tomography; Radionuclide; Adenoid cystic carcinoma; Salivary gland cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] First experiences with 177Lu-PSMA-617 therapy for recurrent or metastatic salivary gland cancer
    Nulent, Thomas J. W. Klein
    van Es, Robert J. J.
    Willems, Stefan M.
    Braat, Arthur J. A. T.
    Devriese, Lot A.
    de Bree, Remco
    de Keizer, Bart
    EJNMMI RESEARCH, 2021, 11 (01)
  • [2] Salivary gland dosimetry in therapy of metastatic castrate-resistant prostate cancer with 177Lu-PSMA-617
    Happel, C.
    Voeller, L.
    Kranert, W. T.
    Baumgarten, J.
    Groener, D.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S102 - S102
  • [3] 177Lu-PSMA-617 for metastatic prostate cancer in India
    Ghose, Aruni
    Banerjee, Soirindhri
    Choudhury, Partha S.
    Maniam, Akash
    Gupta, Manoj
    Banna, Giuseppe L.
    Vasdev, Nikhil
    Ghose, Amit
    Noronha, Vanita
    Mitra, Swarupa
    LANCET REGIONAL HEALTH - SOUTHEAST ASIA, 2024, 30
  • [4] First Experience With 177Lu-PSMA-617 Therapy for Advanced Prostate Cancer in the Netherlands
    van Kalmthout, Ludwike
    Braat, Arthur
    Lam, Marnix
    van Leeuwaarde, Rachel
    Krijger, Gerard
    Ververs, Tessa
    Mehra, Niven
    Bins, Adriaan
    Hunting, Jarmo
    de Keizer, Bart
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : 446 - 451
  • [5] A Hangover Under 177Lu-PSMA-617 Therapy
    Poterszman, Nathan
    Somme, Laura
    Bund, Caroline
    Hutt, Emilie
    Somme, Francois
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (06) : 582 - 583
  • [6] Radiation Dosimetry in 177Lu-PSMA-617 Therapy
    Jackson, Price
    Hofman, Michael
    McIntosh, Lachlan
    Buteau, James Patrick
    Kumar, Aravind Ravi
    SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (02) : 243 - 254
  • [7] 177Lu-PSMA-617 Therapy in a Case of Metastatic Castration-Resistant Prostate Cancer
    Qu, Gengcuo
    Hua, Qingchu
    Li, Hongmei
    Zhang, Yu
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : 152 - 153
  • [8] 177Lu-PSMA-617 radioligand therapy for a patient with lymph node metastatic prostate cancer
    von Eyben, Finn E.
    Kiljunen, Timo
    Joensuu, Timo
    Kairemo, Kalevi
    Uprimny, Christian
    Virgolini, Irene
    ONCOTARGET, 2017, 8 (39) : 66112 - 66116
  • [9] Whole-Body Dosimetry in Therapy of Metastatic Prostate Cancer with 177Lu-PSMA-617
    Happel, C.
    Voeller, L.
    Kranert, W. T.
    Groener, D.
    Bockisch, B.
    Mader, N.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S695 - S695
  • [10] Fractionated 177Lu-PSMA-617 therapy with 101 GBq in a patient with metastatic prostate cancer
    Happel, C.
    Wichert, J.
    Kranert, W. T.
    Voeller, L.
    Bockisch, B.
    Groener, D.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S697 - S697
12345